MR [Mindray Medical International] SD: Section 1 — Conflict Minerals Disclosure Item 1.01

[Section 1 — Conflict Minerals Disclosure Item 1.01 ir.mindray.com Item 1.02 Item 2.01 Mindray Medical International Limited Alex Lung Chief Financial Officer] [In accordance with Rule 13p-1, Mindray undertook a reasonable country of origin inquiry (“RCOI”) to determine whether any of the conflict minerals necessary to the function or production of the products that Mindray manufactures originated in the Democratic Republic of Congo or an adjoining country (“Covered Country”). In conducting its due diligence, Mindray implemented the Conflict Mineral Reporting Template recommended]

MPEL [Melco Crown Entertainment] 6-K: (Original Filing)

[EXPLANATORY NOTE MCE Finance Limited’s Quarterly Report for the Three Months Ended March 31, 2014 This quarterly report serves to provide holders of MCE Finance Limited’s US$1,000,000,000 5.00% senior notes due 2021 (the “ MCE Finance Limited Report for the First Quarter of 2014 TABLE OF CONTENTS INTRODUCTION 1 3 GLOSSARY 4 EXCHANGE RATE INFORMATION 7 FINANCIAL CONDITION AND RESULTS] [EXPLANATORY NOTE Studio City Finance Limited’s Quarterly Report for the Three Months Ended March 31, 2014 Studio City Finance Limited Report for the First Quarter of 2014 TABLE OF CONTENTS INTRODUCTION 1 3 EXCHANGE RATE INFORMATION 4 FINANCIAL CONDITION AND RESULTS OF OPERATIONS 5 INDEX TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS F-1 INTRODUCTION In this quarterly report, unless otherwise indicated:] [Form 6–K TABLE OF CONTENTS]

By | 2016-03-30T03:16:34+00:00 May 30th, 2014|Categories: Chinese Stocks, MPEL, SEC Original|Tags: , , , , , |0 Comments
Skip to toolbar